These predispositions should be interpreted with a qualified healthcare provider to determine if MIC B12 is appropriate for your wellness goals
Causes of Inadequate Responsiveness to Therapy Pseudoresistance White-coat hypertension or office elevations Pseudohypertension in older patients Use of regular adult cuff on a very obese arm Nonadherence to therapy Volume overload Excess salt intake Progressive renal damage (nephrosclerosis) Fluid retention from reduction of blood pressure Inadequate diuretic therapy Drug-related causes Doses too low Wrong type of diuretic Inappropriate combinations Rapid inactivation (e.g., hydralazine) Drug actions and interactions Sympathomimetics Nasal decongestants Appetite suppressants Cocaine and other illicit drugs Caffeine Oral contraceptives Adrenal steroids Licorice (as may be found in chewing tobacco) Cyclosporine or tacrolimus Erythropoietin Antidepressants Nonsteroidal anti-inflammatory drugs Associated conditions Smoking Increasing obesity Sleep apnea Insulin resistance or hyperinsulinemia Ethanol intake of more than 1 oz (30 mL) per day Anxiety-induced hyperventilation or panic attacks Chronic pain Intense vasoconstriction (arteritis) Organic brain syndrome (e.g., memory deficit) Identifiable causes of hypertension Adapted from JNC-7 Express, National Heart, Lung, and Blood Institute
Signs of Progress Track these indicators to assess treatment effectiveness: Reduced pain intensity on a 1-10 scale Decreased pain medication use Improved grip strength (compare dominant to non-dominant hand) Expanded pain-free range of motion Reduced swelling or tenderness on palpation Better sleep quality due to less nighttime discomfort Increased time before pain onset during repetitive activities Reduced reliance on bracing or splinting When Results Disappoint Not everyone responds equally to BPC-157
Clear + Brilliant Clear + Brilliant laser treatment can help prevent the visible signs of aging and address the overall effects time and the environment can have on your skin
This therapy utilizes a small molecule known as 5-Amino-1MQ, which targets an enzyme called Nicotinamide N-methyltransferase (NNMT)
